Universitätsklinikum Aachen — Aachen

Public research footprint of Universitätsklinikum Aachen, compiled from the ClinicalTrials.gov public registry.

164

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Extensive-stage Small Cell Lung Cancer (ES-SCLC) · Primary Generalized Tonic-Clonic Seizures · Atherosclerotic Cardiovascular Disease (ASCVD) · Advanced Renal Cell Carcinoma

Recently updated registry entries

NCT02872987 — GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding… (Recruiting)
NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)
NCT04673357 — A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Universitätsklinikum Aachen?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.